1-benzylimidazole has been researched along with aspirin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boiteux-Antoine, AF; Fournel-Gigleux, S; Knehr, M; Magdalou, J; Oesch, F; Post, K; Schladt, L; Siest, G; Thomas, H | 1 |
Dostert, P; Hartmann, R; Oesch, F; Schladt, L; Strolin-Benedetti, M; Timms, C; Wörner, W | 1 |
Fornabaio, D; Mullane, KM | 1 |
3 other study(ies) available for 1-benzylimidazole and aspirin
Article | Year |
---|---|
Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
Topics: Animals; Aspirin; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Cytosol; Epoxide Hydrolases; Fatty Alcohols; Glucuronosyltransferase; Glutathione Transferase; Guinea Pigs; Hypolipidemic Agents; Imidazoles; Male; Microbodies; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Inbred F344 | 1989 |
Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
Topics: Animals; Aspirin; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Enzyme Induction; Epoxide Hydrolases; Fatty Alcohols; Fenofibrate; Hepatomegaly; Hypolipidemic Agents; Imidazoles; Liver; Male; Microbodies; Microsomes, Liver; Oxidation-Reduction; Palmitoyl-CoA Hydrolase; Probucol; Rats; Rats, Inbred F344 | 1987 |
Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism.
Topics: Acrylates; Animals; Aspirin; Biomechanical Phenomena; Blood Platelets; Coronary Disease; Cyclooxygenase Inhibitors; Dogs; Imidazoles; Methacrylates; Myocardial Infarction; Thromboxane-A Synthase | 1988 |